|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
169,410,000 |
Market
Cap: |
97.83(M) |
Last
Volume: |
3,856,623 |
Avg
Vol: |
3,846,095 |
52
Week Range: |
$0.35 - $0.885 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
37,076 |
Total Sell Value |
$0 |
$0 |
$0 |
$60,923 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
5 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-09-27 |
4 |
S |
$0.62 |
$111,960 |
I/I |
(180,000) |
14,951,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-09-26 |
4 |
S |
$0.62 |
$47,204 |
I/I |
(76,000) |
15,131,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-09-23 |
4 |
S |
$0.63 |
$126,937 |
I/I |
(202,000) |
15,207,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-09-22 |
4 |
S |
$0.66 |
$108,896 |
I/I |
(166,000) |
15,409,400 |
|
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-09-02 |
4 |
B |
$0.69 |
$6,900 |
D/D |
10,000 |
11,912,609 |
3.15 |
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-09-01 |
4 |
B |
$0.70 |
$22,448 |
D/D |
31,887 |
11,902,609 |
3.15 |
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-08-26 |
4 |
B |
$0.66 |
$13,214 |
I/I |
20,021 |
38,530 |
2.56 |
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-08-24 |
4 |
B |
$0.66 |
$50,894 |
I/I |
76,659 |
26,659 |
2.64 |
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-08-23 |
4 |
B |
$0.65 |
$12,928 |
I/I |
20,000 |
20,000 |
2.56 |
- |
|
Collins Morton |
Director |
|
2011-08-23 |
4 |
B |
$0.66 |
$32,815 |
D/D |
50,000 |
465,864 |
2.39 |
- |
|
Collins Morton |
Director |
|
2011-08-11 |
4 |
B |
$0.63 |
$31,495 |
D/D |
50,000 |
415,864 |
2.39 |
- |
|
Dhillon Avtar S |
Executive Chairman |
|
2011-07-06 |
4 |
B |
$0.72 |
$14,400 |
D/D |
20,000 |
233,332 |
2.81 |
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-06-30 |
4 |
S |
$0.61 |
$915,150 |
I/I |
(1,500,000) |
15,575,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-06-29 |
4 |
S |
$0.59 |
$295,050 |
I/I |
(500,000) |
17,075,400 |
|
- |
|
Collins Morton |
Director |
|
2011-06-29 |
4 |
B |
$0.59 |
$29,300 |
D/D |
50,000 |
365,864 |
2.39 |
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-06-28 |
4 |
S |
$0.58 |
$1,154,600 |
I/I |
(2,000,000) |
17,575,400 |
|
- |
|
Benito Simon X |
Director |
|
2011-06-24 |
4 |
B |
$0.57 |
$11,312 |
D/D |
20,000 |
27,189 |
2.39 |
- |
|
Collins Morton |
Director |
|
2011-06-24 |
4 |
B |
$0.58 |
$57,610 |
D/D |
100,000 |
315,864 |
2.39 |
- |
|
Kies Peter |
CFO |
|
2011-06-24 |
4 |
B |
$0.57 |
$13,622 |
D/D |
24,000 |
25,562 |
2.74 |
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-06-16 |
4 |
B |
$0.63 |
$13,688 |
I/I |
21,900 |
15,433,202 |
2.56 |
- |
|
Kim Jong Joseph |
Chief Executive Officer |
|
2011-06-16 |
4 |
B |
$0.63 |
$17,156 |
D/D |
27,450 |
15,433,202 |
3.15 |
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-05-13 |
4 |
S |
$0.92 |
$230,000 |
I/I |
(250,000) |
19,575,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-05-11 |
4 |
S |
$0.92 |
$92,490 |
I/I |
(100,000) |
19,825,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-05-09 |
4 |
S |
$0.91 |
$182,440 |
I/I |
(200,000) |
19,925,400 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-04-18 |
4 |
S |
$1.00 |
$250,600 |
I/I |
(250,000) |
20,125,400 |
|
- |
|
505 Records found
|
|
Page 19 of 21 |
|
|